Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis

OBJECTIVES: IL-36 agonists are pro-inflammatory cytokines involved in the pathogenesis of psoriasis. However, their role in the pathogenesis of arthritis and treatment response to DMARDs in PsA remains uncertain. Therefore, we investigated the IL-36 axis in the synovium of early, treatment-naïve PsA...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutet, Marie-Astrid, Nerviani, Alessandra, Lliso-Ribera, Gloria, Lucchesi, Davide, Prediletto, Edoardo, Ghirardi, Giulia Maria, Goldmann, Katriona, Lewis, Myles, Pitzalis, Costantino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188345/
https://www.ncbi.nlm.nih.gov/pubmed/31504934
http://dx.doi.org/10.1093/rheumatology/kez358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188345/
https://www.ncbi.nlm.nih.gov/pubmed/31504934
http://dx.doi.org/10.1093/rheumatology/kez358

Ejemplares similares